Head-to-head · WeighScore
Piper vs Spry
By GLP-1 ScorecardUpdated
Score comparison
Piper has the higher recorded score — 81.9/100 to 59.2/100.
Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Now branded Polly; compare its complete payment schedule.
Before you choose
Before comparing the headline prices, the Piper review and the Spry review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Piper vs TeleClinic and Renlo Health vs Spry compare each of them with another graded program, and the list of alternatives to Piper ranks the programs closest to Piper on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Piper | Spry |
|---|---|---|
| WeighScore | 81.9/100 | 59.2/100 |
| Grade | B− | C |
| Site position | #29 | #380 |
| Semaglutide | $179 monthly; $135/month equivalent with six months prepaid. | $199/mo (starting dose, compounded) |
| Tirzepatide | $279/mo month-to-month; $199/mo equivalent requires six months and $1,194 prepaid. | $299/mo (starting dose, compounded) |
| Coverage | All-state access claimed; confirm individual eligibility. | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Price FAQs distinguish monthly and prepaid plans.
- All-state access is advertised; individual eligibility needs confirmation.
- Advertises compounded injectable semaglutide and tirzepatide.
What to consider
- Assigned clinicians and dispensing facilities need confirmation.
- Refund cutoffs differ across public pages.
- Confirm the selected monitoring, billing and supply schedule.
Strengths
- Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- No contracts or commitment required
- LegitScript Certified with a public verification link
What to consider
- Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- Intake reviewed by a nurse practitioner, not an MD
- States served not disclosed publicly
- Pharmacy partner not named, and 503A vs 503B designation not specified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.